Eli Lilly and Company (LLY)

913.72 +15.32 (+1.71%) At close: 04:00PM EDT

Eli Lilly and Company

Lilly Corporate Center
Indianapolis, IN 46285
United States
317 276 2000
https://www.lilly.com

Sector(s): Healthcare
Industry: Drug Manufacturers - General
Full-time employees: 43,000

Key executives

Name	Title	Pay	Exercised	Year born
Mr. David A. Ricks	Chairman, CEO & President	6.29M	N/A	1968
Dr. Daniel M. Skovronsky M.D., Ph.D.	EVP, Chief Scientific Officer and President of Lilly Research Laboratories & Lilly immunology	3.82M	N/A	1974
Ms. Anat Hakim J.D.	Executive VP, General Counsel & Secretary	2.81M	N/A	1969
Mr. Jacob S. Van Naarden	Executive VP & President of Loxo	2.38M	N/A	1985
Mr. Lucas E. Montarce	Executive VP & CFO	N/A	N/A	1977
Mr. Donald A. Zakrowski	Senior VP of Finance & Chief Accounting Officer	N/A	N/A	N/A
Mr. Diogo Rau	EVP & Chief Information and Digital Officer	1.06M	N/A	1975
Mr. Alonzo Weems	EVP of Enterprise Risk Management and Chief Ethics & Compliance Officer	N/A	N/A	1971
Mr. Eric Dozier	Executive Vice President of Human Resources & Diversity	N/A	N/A	1968
Mr. Jeffrey N. Simmons	Senior VP & President of Elanco Animal Health	1.73M	N/A	1967

Amounts are as of 31 December 2023, and compensation values are for the last fiscal year ending on that date. Pay includes salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.

Description

Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. The company offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; Jardiance, Mounjaro, and Trulicity for type 2 diabetes; and Zepbound for obesity. It also provides oncology products, including Alimta, Cyramza, Erbitux, Jaypirca, Retevmo, Tyvyt, and Verzenio. In addition, the company offers Olumiant for rheumatoid arthritis, atopic dermatitis, severe alopecia areata, and COVID-19; Taltz for plaque psoriasis, psoriatic arthritis, ankylosing spondylitis, and non-radiographic axial spondylarthritis; Omvoh for ulcerative colitis; Cymbalta for depressive disorder, diabetic peripheral neuropathic pain, generalized anxiety disorder, fibromyalgia, and chronic musculoskeletal pain; Ebglyss for severe atopic dermatitis; and Emgality for migraine prevention and episodic cluster headache. Further, it provides Cialis for erectile dysfunction and benign prostatic hyperplasia; and Forteo for osteoporosis. The company operates Lilly Seaport Innovation Center (LSC), a research and development facility in the Boston Seaport to advancing Lilly's efforts in RNA and DNA-based therapies as well as discovering new drug targets to create life-changing medicines across several disease states, including diabetes, obesity, cardiovascular diseases, neurodegeneration, and chronic pain. It has collaborations with Incyte Corporation; Boehringer Ingelheim Pharmaceuticals, Inc.; F. Hoffmann-La Roche Ltd and Genentech, Inc.; Biologics, Inc., AbCellera Biologics Inc.; and Chugai Pharmaceutical Co., Ltd, as well as development collaboration with Eli Lilly and Company for developing QIAstat-Dx IVD panel, for the detection of various APOE genotypes. The company was founded in 1876 and is headquartered in Indianapolis, Indiana.

Corporate governance

Eli Lilly and Company’s ISS governance QualityScore as of 1 October 2024 is 5. The pillar scores are Audit: 4; Board: 4; Shareholder rights: 9; Compensation: 1.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while 10 indicates higher governance risk.